FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002208369> ?p ?o ?g. }

• W2002208369 endingPage "175" @default.
• W2002208369 startingPage "173" @default.
• W2002208369 abstract "NanomedicineVol. 7, No. 2 EditorialThe impact of nanotechnology on myocardial infarction treatmentDenis B BuxtonDenis B BuxtonBasic & Early Translational Research Program, Division of Cardiovascular Sciences, National Heart, Lung & Blood Institute, 6701 Rockledge Drive, Bethesda MD 2089, USA. Search for more papers by this authorEmail the corresponding author at db225a@nih.govPublished Online:17 Feb 2012https://doi.org/10.2217/nnm.11.184AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: diagnosticsmyocardial infarctionnanotechnologyregenerative medicinetherapeutic deliveryReferences1 Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation123,e18–e209 (2011).Crossref, Medline, Google Scholar2 Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol.8,30–41 (2011).Crossref, Medline, Google Scholar3 Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 trial. Am. Heart J.158,386–391 (2009).Crossref, Medline, CAS, Google Scholar4 Goluch ED, Nam JM, Georganopoulou DG et al. A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip6,1293–1299 (2006).Crossref, Medline, CAS, Google Scholar5 Gray WD, Che P, Brown M, Ning X, Murthy N, Davis ME. N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing. J. Cardiovasc. Transl. Res.4,631–643 (2011).Crossref, Medline, Google Scholar6 Dvir T, Bauer M, Schroeder A et al. Nanoparticles targeting the infarcted heart. Nano Lett.11,4411–4414 (2011).Crossref, Medline, CAS, Google Scholar7 Swirski FK, Nahrendorf M, Etzrodt M et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science325,612–616 (2009).Crossref, Medline, CAS, Google Scholar8 Leuschner F, Dutta P, Gorbatov R et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol.29,1005–1010 (2011).Crossref, Medline, CAS, Google Scholar9 Lin YD, Yeh ML, Yang YJ et al. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation122(Suppl. 11),S132–S141 (2010).Crossref, Medline, CAS, Google Scholar10 Segers VFM, Lee RT. Local delivery of proteins and the use of self-assembling peptides. Drug Discov.Today.12,561–568 (2007).Crossref, Medline, CAS, Google Scholar11 Kim JH, Jung Y, Kim SH et al. The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials32,6080–6088 (2011).Crossref, Medline, CAS, Google Scholar12 Orlova Y, Magome N, Liu L, Chen Y, Agladze K. Electrospun nanofibers as a tool for architecture control in engineered cardiac tissue. Biomaterials32,5615–5624 (2011).Crossref, Medline, CAS, Google Scholar13 Dvir T, Timko BP, Brigham MD et al. Nanowired three-dimensional cardiac patches. Nat. Nanotechnol.6,720–725 (2011).Crossref, Medline, CAS, Google Scholar14 Zhang B, Xiao Y, Hsieh A, Thavandiran N, Radisic M. Micro- and nanotechnology in cardiovascular tissue engineering. Nanotechnology22,494003 (2011).Crossref, Medline, Google Scholar15 Kenar H, Kose GT, Toner M, Kaplan DL, Hasirci V. A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials32,5320–5329 (2011).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited BymiRNA transfection via poly(amidoamine)-based delivery vector prevents hypoxia/reperfusion-induced cardiomyocyte apoptosisNida Sayed, Prajakta Tambe, Pramod Kumar, Sachin Jadhav, Kishore M Paknikar & Virendra Gajbhiye4 December 2019 | Nanomedicine, Vol. 15, No. 2Application and limitation of nanomedicine in different cardiovascular disease3 July 2018 | International Journal of Pharma and Bio Sciences, Vol. 9, No. 3Molecular assessment of protective effect of Vitex negundo in ISO induced myocardial infarction in ratsBiomedicine & Pharmacotherapy, Vol. 92The potential for nanotechnology to improve delivery of therapy to the acute ischemic heartCameron W Evans, K Swaminathan Iyer & Livia C Hool16 March 2016 | Nanomedicine, Vol. 11, No. 7Nanomedicines for endothelial disordersNano Today, Vol. 10, No. 6Combining photobiology and nanobiotechnology: a step towards improving medical protocols based on advanced biological modelsFernando Lucas Primo & Antonio Claudio Tedesco5 April 2013 | Nanomedicine, Vol. 8, No. 4Nanotechnology in Anesthesia and MedicineAdvances in Anesthesia, Vol. 31, No. 1 Vol. 7, No. 2 Follow us on social media for the latest updates Metrics Downloaded 462 times History Published online 17 February 2012 Published in print February 2012 Information© Future Medicine LtdKeywordsdiagnosticsmyocardial infarctionnanotechnologyregenerative medicinetherapeutic deliveryFinancial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W2002208369 created "2016-06-24" @default.
• W2002208369 creator A5002243330 @default.
• W2002208369 date "2012-02-01" @default.
• W2002208369 modified "2023-10-14" @default.
• W2002208369 title "The impact of nanotechnology on myocardial infarction treatment" @default.
• W2002208369 cites W1967778440 @default.
• W2002208369 cites W1970516435 @default.
• W2002208369 cites W1975326759 @default.
• W2002208369 cites W1984294186 @default.
• W2002208369 cites W1992644002 @default.
• W2002208369 cites W2003870922 @default.
• W2002208369 cites W2030192764 @default.
• W2002208369 cites W2035066344 @default.
• W2002208369 cites W2041663579 @default.
• W2002208369 cites W2042064887 @default.
• W2002208369 cites W2062164427 @default.
• W2002208369 cites W2087495634 @default.
• W2002208369 cites W2097438103 @default.
• W2002208369 cites W2097862412 @default.
• W2002208369 cites W2157571064 @default.
• W2002208369 cites W4292172722 @default.
• W2002208369 doi "https://doi.org/10.2217/nnm.11.184" @default.
• W2002208369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22339129" @default.
• W2002208369 hasPublicationYear "2012" @default.
• W2002208369 type Work @default.
• W2002208369 sameAs 2002208369 @default.
• W2002208369 citedByCount "9" @default.
• W2002208369 countsByYear W20022083692013 @default.
• W2002208369 countsByYear W20022083692015 @default.
• W2002208369 countsByYear W20022083692016 @default.
• W2002208369 countsByYear W20022083692017 @default.
• W2002208369 countsByYear W20022083692020 @default.
• W2002208369 countsByYear W20022083692022 @default.
• W2002208369 countsByYear W20022083692023 @default.
• W2002208369 crossrefType "journal-article" @default.
• W2002208369 hasAuthorship W2002208369A5002243330 @default.
• W2002208369 hasConcept C126322002 @default.
• W2002208369 hasConcept C161191863 @default.
• W2002208369 hasConcept C185592680 @default.
• W2002208369 hasConcept C2779473830 @default.
• W2002208369 hasConcept C41008148 @default.
• W2002208369 hasConcept C500558357 @default.
• W2002208369 hasConcept C55493867 @default.
• W2002208369 hasConcept C71924100 @default.
• W2002208369 hasConceptScore W2002208369C126322002 @default.
• W2002208369 hasConceptScore W2002208369C161191863 @default.
• W2002208369 hasConceptScore W2002208369C185592680 @default.
• W2002208369 hasConceptScore W2002208369C2779473830 @default.
• W2002208369 hasConceptScore W2002208369C41008148 @default.
• W2002208369 hasConceptScore W2002208369C500558357 @default.
• W2002208369 hasConceptScore W2002208369C55493867 @default.
• W2002208369 hasConceptScore W2002208369C71924100 @default.
• W2002208369 hasIssue "2" @default.
• W2002208369 hasLocation W20022083691 @default.
• W2002208369 hasLocation W20022083692 @default.
• W2002208369 hasOpenAccess W2002208369 @default.
• W2002208369 hasPrimaryLocation W20022083691 @default.
• W2002208369 hasRelatedWork W1506200166 @default.
• W2002208369 hasRelatedWork W1995515455 @default.
• W2002208369 hasRelatedWork W2048182022 @default.
• W2002208369 hasRelatedWork W2080531066 @default.
• W2002208369 hasRelatedWork W2604872355 @default.
• W2002208369 hasRelatedWork W2748952813 @default.
• W2002208369 hasRelatedWork W2899084033 @default.
• W2002208369 hasRelatedWork W3031052312 @default.
• W2002208369 hasRelatedWork W3032375762 @default.
• W2002208369 hasRelatedWork W3108674512 @default.
• W2002208369 hasVolume "7" @default.
• W2002208369 isParatext "false" @default.
• W2002208369 isRetracted "false" @default.
• W2002208369 magId "2002208369" @default.
• W2002208369 workType "article" @default.